Independent, evidence-based peptide science intelligence. Our editorial team combines expertise in peptide chemistry, molecular pharmacology, and biotech industry analysis.
Syn-Ake blocks muscle nicotinic receptors directly — not through SNARE proteins like Argireline. A deep dive into the viper-venom-inspired peptide with new clinical data from a 2026 L'Oreal study.
Palmitoyl Tripeptide-1 triggers collagen without copper. The science behind this matrikine peptide, its clinical data, and what experienced formulators know.
Syn-Ake is a synthetic tripeptide modeled on temple viper venom that competes with acetylcholine at neuromuscular receptors to reduce wrinkle-causing muscle contractions. Clinical data shows 35 to 69 percent static wrinkle improvement at 12 weeks.
Matrixyl sends a fake distress signal to fibroblasts using a five-amino-acid collagen fragment called KTTKS. Here is the full molecular mechanism, clinical data, and what formulators get wrong about concentration and delivery.